GENEVA, Nov. 19 -- UMOJA BIOPHARMA, INC. (1150 Eastlake Ave E., Suite 400Seattle, Washington 98109) filed a patent application (PCT/US2025/028138) for "MULTISPECIFIC IMMUNE CELL ENGAGER AND USES THEREOF" on May 07, 2025. With publication no. WO/2025/235605, the details related to the patent application was published on Nov 13, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): QIN, Jim, NICOLAI, Christopher
Abstract: Provided here are immune cell engagers and multispecific immune cell engagers. Some such embodiments include an adhesion molecule linked to a costimulatory molecule or an immune c...